We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
6665 Background: Optimal HDC strategy in breast cancer remains to be defined. This phase III trial evaluates the role of the number of HDC cycles. METHODS From 2/97 to 6/01 we randomised 187(More)
  • 1